Micro-cap Bulls: Galectin Therapeutics (NASDAQ:GALT), Cinedigm Corp (NASDAQ:CIDM), Aviat Networks (NASDAQ:AVNW), Zhone Technologies (NASDAQ:ZHNE)
Galectin Therapeutics Inc. (NASDAQ:GALT), a young, NASDAQ-traded company is fighting this ailment with GR-MD-02, a new drug with encouraging Phase I clinical-trial results. But Galectin Therapeutics Inc. (NASDAQ:GALT)’s progress comes amid frequent migraines, thanks to federal regulations. Galectin Therapeutics Inc. (NASDAQ:GALT) executive chairman James C. Czirr blames “all three of the bad boys” Sarbanes-Oxley, Dodd-Frank,…
